Expert commentators

Expert commentators

The following clinicians contributed to this briefing:

  • Benjamin Ayres, consultant urological surgeon, St Georges University Hospital NHS Foundation Trust. Has received funding to attend conferences and lecture fees for teaching. Was also involved in a trial of pembrolizumab in high-risk non-muscle-invasive bladder cancer as chief investigator for the UK.

  • James Catto, professor in urological surgery, University of Sheffield, Sheffield Teaching Hospitals NHS Trust. Involved in a trial of using erdafitnib in people whose disease did not respond to Bacille Calmette‑Guérin (BCG) treatment and a clinical trial comparing BCG with radical cystectomy in people who had not had BCG treatment.

  • Sanjeev Madaan, consultant urological surgeon and lead cancer clinician, Darent Valley Hospital. Did not declare any interests.